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Manuscript # E-00237-2006.R1 4 the formation of dimethylglycine and methionine (14) . Alternatively, homocysteine can be remethylated through the donation of a methyl group from 5-methyltetrahydrofolate (5-CH 3 -THF) via the B 12 -dependent enzyme methionine synthase (MS), resulting in tetrahydrofolate (THF) and methionine. An inability of the cell to remethylate or catabolize homocysteine can result in hyperhomocysteinemia, an independent risk factor for cardiovascular disease (8, 26) .
Because of its central role in methyl group and homocysteine metabolism, the regulation of GNMT is an important control point. In a state of excess methyl groups, the resulting increase in SAM acts as an allosteric inhibitor of the enzyme 5,10-methylenetetrahydrofolate reductase (MTHFR) (25, 29) , decreasing its activity and the subsequent production of 5-CH 3 -THF. This alleviates the negative allosteric regulation 5-CH 3 -THF imposes on GNMT, thereby increasing its activity and disposing of the excess methyl groups. Conversely, a lack of methyl groups results in an increase in MTHFR activity and 5-CH 3 -THF concentrations, thereby inhibiting GNMT and conserving methyl groups for transmethylation reactions (55).
A type 1 diabetic state has been identified as a pathological factor in the modulation of methyl group and homocysteine metabolism. A reduction in circulating concentrations of homocysteine as a result of increased catabolism through the transsulfuration pathway, namely by the transcriptional regulation of CBS, has been demonstrated in a streptozotocin (STZ)-induced diabetic rat model (22, 40) . Recently, we have shown that a diabetic state leads to the disruption of hepatic methyl group metabolism, characterized by elevations in GNMT activity and abundance, as well as an increase in the folate-independent remethylation of homocysteine by BHMT (33) . Similarly, administration of specific counterregulatory hormones (e.g., dexamethasone, glucagon) have also been shown to alter methyl group and homocysteine metabolism both in vivo and in vitro (23, 45) . Because the folate-dependent one-carbon pool Page 4 of 34 
Manuscript # E-00237-2006.R1 5 supplies methyl groups for the remethylation of homocysteine and SAM-dependent transmethylation reactions, and serves as a regulatory mechanism for the control of GNMT activity via allosteric inhibition by 5-CH 3 -THF, the aim of these studies was to examine how dietary folate status may impact the previously reported findings. We have also extended our earlier studies by examining the activity of PEMT, because it is a key enzyme in the SAMdependent synthesis of PC and regulation of homocysteine homeostasis (35, 47) .
MATERIALS AND METHODS

Chemicals and reagents.
Reagents used in the research methods were obtained from the 
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Manuscript # E-00237-2006.R1 6 rats were anesthetized 3-4 h into the light cycle with a single intraperitoneal injection of ketamine: xylazine (90: 10 mg/kg body weight) and heparinized whole blood was collected by cardiac puncture. An aliquot was removed for the determination of blood glucose concentrations using a commercial kit (Sigma-Aldrich); the remaining whole blood sample was centrifuged at 4,000 × g for 6 min and the plasma was removed for storage at -20°C for subsequent analysis of homocysteine concentrations. Portions of the liver were rapidly removed and homogenized in four volumes of ice-cold buffer containing 10 mM sodium phosphate (pH 7.0), 0.25 M sucrose, 1 mM EDTA, 1 mM sodium azide, and 0.1 mM phenylmethylsulfonyl fluoride. Homogenates were centrifuged at 20,000 × g for 30 min and the resulting supernatant was stored at -70°C after the addition of L-mercaptoethanol to a final concentration of 1 mM. These samples were used for the determination of enzyme activities (GNMT, BHMT, MS) and abundance (GNMT). A second liver sample was homogenized in 4 volumes of ice-cold sodium acetate buffer (100 mM, pH 4.9) containing 0.5% ascorbate and 20 mM 2-mercaptoethanol under a steady stream of nitrogen, tightly capped, and stored at -70°C for determination of hepatic folate concentrations.
Additional whole liver samples were placed in liquid nitrogen or RNAlater (Qiagen) and stored at -70°C for subsequent isolation of microsomes (PEMT) or mRNA (GNMT, BHMT), respectively. Total soluble protein concentration of the supernatants was determined using a commercial kit (Coomassie Plus, Pierce) based on the Bradford method (2) and bovine serum albumin as a standard. All enzyme assays were linear with respect to protein concentration and incubation time.
Determination of GNMT activity and abundance. The enzymatic activity of GNMT was measured based on the method of Cook and Wagner (9) with slight modifications (45). The assay was performed in triplicate using 250 µg protein and a reaction mixture containing the (12) with modifications. This specific assay using endogenous phosphatidylethanolamine (PE) has been shown to accurately determine PEMT activity equivalent to methods that add exogenous PE to the incubation mixture (3, 18) . Briefly, the reaction mixture contained 10 mM HEPES (pH 7.3), 4 mM dithiothreitol, 5 mM MgCl 2 , 0.1 MS and BHMT activity analysis. MS activity was analyzed using the method described by Keating et al. (27) . The assay was initiated with 600 µg of protein added to a reaction 37°C, samples were chilled, ice-cold water added, and applied to Dowex 1-X4 columns. Eluted fractions were collected in scintillation vials and radioactivity was measured by liquid scintillation counting. One unit of BHMT activity was equivalent to the production of 1 nmol of methionine per hour (38) . For both assays, fresh homocysteine was prepared daily from the thiolactone derivative (16) .
Determination of GNMT and BHMT mRNA abundance. Total mRNA was isolated from frozen liver using a commercial reagent kit (RNAeasy , Qiagen) and quantified by UV detection. Northern blot analysis was performed as described previously (49 To normalize RNA expression, membranes were stripped and rehybridized with labeled rat glyceraldehyde-3-phosphate dehydrogenase (GAPDH) cDNA probes (Ambion, Inc., Austin, TX). Measurement of hepatic folate concentrations. THF and 5-CH 3 -THF were determined using HPLC and fluorometric detection according to Rebello (41) with some minor modifications (37) . Briefly, frozen homogenates were thawed and placed in a boiling water bath for 60 min and following centrifugation at 20,000 × g for 10 min, rat serum conjugase was added to an aliquot of the resulting supernatant and incubated for 1 h at 37 °C. Following activation of Sep-Pak NH 2 columns with acetonitrile and 16 mM sodium acetate buffer (pH 4.5), samples were applied and washed with acetate buffer and sodium phosphate (100 mM) containing 50 mM 2-mercaptoethanol. Folate coenzymes were separated on a Phenyl Radial-Pak column (Waters Associates, Milford, MA) and quantified using fluorometric detection.
Statistical analysis.
The mean values of each treatment group were analyzed by a twoway ANOVA using SigmaStat software (SPSS, Chicago, IL) at a significance level of 5% and compared using Fisher's least significant difference procedure (48). Mean GNMT and BHMT mRNA values in control and diabetic rats were analyzed by a Student's t-test (P<0.05).
RESULTS
Confirmation of differential folate status and a diabetic state in rats.
Neither STZ treatment nor dietary folate levels had a significant effect on the weight gain (Table 1 ). Blood glucose concentrations in STZ-treated rats were approximately 2-fold greater in all diet groups compared to their respective controls, regardless of dietary folate levels. Control rats fed the folate-deficient diet exhibited an 84% reduction in total hepatic folate coenzyme concentrations, whereas they were increased 56% by folate supplementation (FD, 1.18 ± 0.11; F, 7.37 ± 0.92; FS, 11.53 ± 0.94 nmol/g liver). Taken together, the data indicates that rats were in a moderate state of diabetes and altered folate status. Folate-containing diets attenuated GNMT activity in diabetic rats, but was without effect on abundance. Mild folate deficiency in diabetic rats resulted in a 200% induction of GNMT activity as compared to non-diabetic controls ( Fig. 2A) . However, this induction was significantly attenuated 64 and 74% in treatment groups fed the folate-adequate and folatesupplemented diets, respectively, compared to diabetic rats fed a folate-deficient diet. In contrast, GNMT abundance was elevated to the same extent in all diabetic rats regardless of dietary folate (Fig. 2B) . Taken together, these results indicate that adequate dietary and subsequently hepatic folate concentrations attenuated the diabetes-mediated increase in GNMT activity, likely by posttranslational control.
Hyperhomocysteinemia in folate-deficient rats was attenuated by streptozotocin (STZ)-
induced diabetes. Folate-deficient animals exhibited a 4-to 5-fold increase in total plasma homocysteine concentrations compared to animals fed either the folate-adequate or folatesupplemented diet (Fig. 3) . However, homocysteine levels in folate-deficient diabetic rats were only 54% of that exhibited by non-diabetic rats. As expected, normal homocysteine concentrations were observed in folate-adequate and folate-supplemented control rats. The lower mean homocysteine concentrations in diabetic rats provided an adequate or supplemented folate diet were similar.
Diabetes elevated the hepatic activity of SAM-dependent PEMT and the folate-
independent homocysteine remethylation enzyme BHMT, whereas the folate-dependent remethylation enzyme MS was diminished in diabetic rats. The enzymatic activity of PEMT was determined as it is a major user of methyl groups from SAM, thereby reflecting methyl group homeostasis, as well as a regulator of homocysteine balance. As shown in Table 2 , the activity of PEMT was increased ~2-fold in all diabetic rats, regardless of dietary folate. The enzymatic GNMT and BHMT mRNA abundance were increased in diabetic rats. The elevated activity of BHMT and GNMT in diabetic rats was reflected in the abundance of their respective mRNAs. GNMT and BHMT mRNA levels were elevated 6.5-and 1.9-fold in diabetic rats, respectively, compared to the non-diabetic animals (Fig. 4) .
DISCUSSION
Understanding the nutritional and/or physiologic factors that modulate folate, homocysteine, choline, and methyl group metabolism is critical towards the prevention of numerous pathologies associated with perturbation of these pathways (26, 43, 46) . We have shown previously (33) that a type 1diabetic state results in modulation of methyl group metabolism by increasing the enzymatic activity and protein abundance of GNMT, a key hepatic protein in the regulation of methyl group supply from the folate-dependent one carbon pool and its utilization for SAM-dependent transmethylation reactions. Because induction of GNMT function would be expected to result in a loss of methyl groups as well as contribute to homocysteine production, developing intervention strategies directed at restoring normal GNMT function is important. Thus, the aim of this research was to determine the impact varying degrees of folate status has on diabetes and methyl group metabolism, particularly as the folate Although these results would suggest that adequate folate status has a positive effect under diabetic conditions, supplemental folate did not confer any added benefit. Providing folate at levels ~20-fold greater than our studies here, others have shown that folate supplementation by injection was an effective means to reduce embryo malformations in diabetic rats (57). Thus, it will be important in future research to determine if a greater reduction in GNMT activity can be achieved with higher doses of folate, route of supplementation, and/or longer treatment times.
The marked hyperhomocysteinemia exhibited in the folate-deficient rats was surprising, given that the degree of folate deficiency would appear to be moderate. This assessment is based on the findings that no changes were seen in growth and an antibiotic was not added to the drinking water to eliminate bacterial folate production. A similar 4-wk study design with the inclusion of an antibiotic resulted in only a 2-fold increase in plasma homocysteine concentrations (20) . However, we found that hepatic folate concentrations were only 16% of that observed for folate adequate rats. Hyperhomocysteinemia in folate-deficient rats was significantly attenuated as a result of diabetes, likely the result of an increase in BHMT activity. Our previous work and others have shown that a diabetic condition can also reduce circulating homocysteine levels as a result of increased homocysteine catabolism via CBS (22, 33, 40) . In contrast to previous studies (22, 33, 40) , hypohomocysteinemia was not statistically evident in folate-adequate or folate-supplemented rats receiving an amino acid-defined diet.
We have extended our previous work by demonstrating that the induction of GNMT and BHMT is reflected in the abundance of their respective mRNAs. It is not known what signal results in increased mRNA of these proteins, either by a transcriptional mechanism or through mRNA stability. Previous studies have shown that various hormones (e.g., dexamethasone) and relevant metabolites (e.g., methionine, SAM) have the ability to directly regulate the expression of these proteins (7, 44, 45) . Ultimately, the induction of GNMT and BHMT would be expected to have an impact on other SAM-dependent methyltransferases and choline metabolism, respectively.
For humans, there are numerous reports in the literature that have found both type 1 and type 2 diabetes are associated with hyperhomocysteinemia, thereby establishing a potential link to increased cardiovascular disease risk (19, 32, 39, 42) . The hypohomocysteinemia that has been reported by our laboratory and others (22, 33, 40) is likely due to the role of the kidneys in homocysteine metabolism. The progression from a hypo-to a hyperhomocysteinemic state may be the result of renal dysfunction (39) , as the kidneys play a significant role in the metabolism of homocysteine (1, 13) . Taken together with the findings reported here, it is clear that future research will need to be directed at understanding the tissue-specific temporal changes in methyl group and homocysteine metabolism as a function of diabetes progression. This knowledge will be vital in the development of dietary and/or therapeutic intervention strategies aimed at preventing disruption of these pathways by a diabetic condition. A novel finding reported here is the up-regulation of the enzymatic activity of PEMT by diabetes. There are numerous studies that have examined the impact of a diabetic state on the regulation of PEMT activity and PC synthesis; however, the reports are conflicting and appear to vary depending on the animal model, method for inducing diabetes, and the type of tissues examined (4,6,50,60). The action of PEMT constitutes a major route for utilization of the labile methyl groups from SAM (24) and thus would be expected to provide some index of methyl group availability. Moreover, PEMT is responsible for ~30% of PC production with the remainder being derived directly from choline pools. Our observed increase in PEMT activity may reflect a shift from using PE, rather than choline directly, for PC synthesis owing to the loss of choline, as betaine, for BHMT and homocysteine remethylation.
PEMT expression and function has been reported to significantly influence homocysteine production and secretion (35, 47) . Moreover, it has been proposed to represent a more significant use for SAM-derived methyl groups, as opposed to SAM-dependent synthesis of creatine (24) . These previous studies reported that homocysteine secretion positively associated with inducing expression of PEMT in hepatoma cells, and a complete lack of PEMT expression resulted in low circulating levels of homocysteine in PEMT knockout mice (35, 47) . Similarly, a 2-fold increase in PEMT activity, similar to the elevation we have observed in diabetic rats, in CTP:phosphocholine cytidylytransferase-knockout mice also resulted in an increase in homocysteine production and secretion (24) . Thus, the absence of PEMT expression or increasing its expression in cells that have low levels of expression appears to regulate homocysteine balance. However, our studies indicate that an increase in hepatic PEMT activity in vivo, as the result of a diabetic state, does not have a concomitant alteration in circulating homocysteine levels. It is likely that the diabetes-mediated increase in PEMT, as well as GNMT, does result in an increase in homocysteine production, but stimulation of BHMT expression is a compensatory mechanism to prevent homocysteine pools from accumulating. Moreover, irreversible catabolism of homocysteine by the transsulfuration pathway and the initial action of CBS has been shown to be activated by diabetes and glucocorticoids (22, 40) .
The collective induction of PEMT, GNMT, and BHMT, combined with diminished MS activity, indicates that diabetes is characterized by a deficiency of methyl groups and an increased requirement for choline. This is supported by our preliminary studies that found the hepatic synthesis of creatine was significantly decreased ~50% in diabetic rats (CS Hartz and KL Schalinske, unpublished observations), indicating that the induction of GNMT and PEMT results in a deficiency of adequate methyl groups for other SAM-dependent transmethylation reactions.
To that extent, we have found that diabetes is characterized by hypomethylation of DNA in rat liver (59). The utilization of PC for bile secretion is greatly enhanced in the diabetic state (53) and PC requirements correlate to PEMT activity (21) . Ultimately, studies that focus on the measurement of metabolic flux through these pathways, similar to what has been recently reported (10,11) needs to be performed to definitively evaluate the effect of diabetes. Recently, a kinetic study with human subjects demonstrated that transmethylation, homocysteine transsulfuration, and clearance of homocysteine were significantly reduced in type 2 diabetes with nephropathy (51).
It is also clear from our findings that the observations reported here are specific for a diabetic state and not the result of using a chemically-induced model. This is supported by the fact that we, and others, have found similar changes using an either alloxan-mediated model, or 
